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INTRODUCTION 
 
 
Pain is an unpleasant sensory and emotional experience that occurs 
in  response to tissue damage.Every patient has the right to get rid of pain 
and it is the duty of every anaesthetist to provide adequate pain relief. 
 
Pain relief is provided by various methods like oral drugs , nerve 
blocks but adequate pain relief is provided by interrupting the transmission 
of pain. Peripheral nerve blocks provide longer and more localized pain 
relief than systemic opioids and non-steroidal anti-inflammatory drugs.  
In 1884,Koller demonstrated cocaine in ocular surface anaesthesia 
which was a new era in regional anaesthesia for the prevention of pain. 
And later Brachial plexus block has evolved in procedures for upper limb 
surgeries when William Halstead performed it for the first time in 1884.        
Brachial plexus block is performed as a supplementation to general 
anaesthesia to reduce the analgesic requirements, better tourniquet 
tolerance as well as to provide post operative analgesia.Brachial plexus is 
used as a sole anaesthetic technique in situation where general anaesthesia 
is relatively contraindicated (eg) emergency situation where the starvation 
time is inadequate, and if proper precautions are not taken, may lead to 
aspiration of stomach contents.  
                                               
 
  
Successful brachial plexus block for upper limb surgeries requires 
wide knowledge about the anatomy of its origin and its branches, 
complications that would occur in various approaches as well as the 
clinical application of local anaesthetics and various adjuvants added to it 
inorder to provide better quality of blockade as well as prolong the duration 
of post operative analgesia. At the same time the motor blockade should 
not be prolonged for a long time that prolongs the hospital stay. 
Brachial plexus can be easily blocked because they lie in a sheath 
and by eliciting paraesthesia of one of the roots/trunk/cords can give a 
success rate by injecting large volume of local anaesthetic solution.  
  Most of the local anaesthetics developed between 1900-1940 were 
amino ester compounds like cocaine, procaine, chloroprocaine but they 
were associated with allergic reactions and short duration of action.Lofgren 
and associates synthesized lignocaine and Ekenstam synthesized 
Bupivacaine which improved the quality of Regional anaesthesia. Though 
lignocaine is short acting it is widely used till date. Bupivacaine, an amide 
local anaesthetic witha  longer duration of  action is also used in nerve 
blocks. 
In most of the peripheral nerve blocks lignocaine and bupivacaine 
are mixed  together and used. Lignocaine provides early onset of blockade                               
whereas  bupivacaine prolongs the duration of blockade. Ifan inadvertant 
  
accidental injection of these two drugs occurs they produce serious 
complications involving  cardiovascular and central nervous system. Hence 
in this study only bupivacaine is used  so that side effect of atleast one drug 
is avoided if a situation arises to face the detrimental effects of local 
anaesthetic toxicity  if accidentally injected intravascularly. 
In order to provide better anaesthesia in the intraoperative period as 
well as to provide better analgesia in the post operative period,various 
adjuvants are added to local anaesthetic solution like Sodiumbicarbonate, 
Potassiumchloride, Adrenaline,Dexmedetomidine,Clonidine, Midazolam, 
Fentanyl,Tramadol, Dexamethasone, etc. 
Adjuvants are added to improve the quality of anaesthesia and also to 
improve the duration of post operative analgesia. Classically Adrenaline is 
added which  prevents the systemic absorption of the local anaesthetics and 
thus prolongs the duration of analgesia. But it has got detrimental effect of 
increasing the heart rate, blood pressure, and thereby it can cause coronary 
vasoconstriction. The other adjuvants  can cause side effects like vomiting, 
pruritis, altered hemodynamic stability, sedation etc. 
   In this study 30ml of 0.375% of Bupivacaine with 0.2mmol(0.1ml) 
of  potassium chloride of 15% solution which contains 20mmol/10ml is 
compared with 30ml of 0.375% of Bupivacaine with 0.179 mmol(0.2ml) of 
7.5% of sodiumbicarbonate which contains 0.893mmol/litre regarding the 
  
quality and quantity of blockade in brachial plexus block for upperlimb 
surgeries. 
 
 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
AIM OF THE STUDY 
 TO COMPARE THE EFFICACY OF POTASSIUM CHLORIDE AND 
SODIUM BICARBONATE AS AN ADJUVANT TO BUPIVACAINE IN 
SUPRACLAVICULAR SUBCLAVIAN PERIVASCULAR APPROACH 
OF BRACHIAL PLEXUS BLOCK.THE FOLLOWING PARAMETERS 
WERE COMPARED BETWEEN THE TWO GROUPS. 
1.Onset of sensory block 
2.Onset of motor block 
3.Tourniquet tolerance 
4.Duration of sensory block 
5.Duration of motor block 
6.Quality of block 
7. Hemodynamic stability 
8.Complications. 
 
 
 
 
HISTORY 
 
 During sixteenth and seventeenth century a French surgeon Ambrose 
produced local anaesthesia by mechanical compression of nerve trunks which 
was later followed by many European surgeons. In 1860 NIEMANN extracted 
cocaine from coca leaves.  
 Carl Koller,an young Ophthalmologist from Vietnam performed 
experiments on himself and proved that cocaine had local anaesthetic effects. 
He used cocaine as topical anaesthetic and applied it on his own cornea . 
In 1884, WILLIAM HALSTEAD(1852-1922)(1) first performed Brachial 
plexus at the level of their roots with cocaine and thereby he “freed the cords 
and nerves of the brachial plexus”. 
WILLIAM HALSTED (1852-1922)(1) injected cocaine in to the nerve 
trunks and later his technique was followed by ALFRED HALL. Halsted and 
Hall worked together and they reported their success which was published on 
December 6,1884 in NewYork medical journal.  
In 1887,GEORGE CRILE(1) introduced the technique of infiltrating the 
nerves  under general anaesthesia to reduce stress and shock of surgery by using 
0.5% cocaine.He first  blocked the Brachial plexus and disarticulated the 
shoulder joint. 
 
 
                                                  
  
ALFRED HALL(1) reported that injecting 4%Cocaine (15mg) in to the forearm 
blocked the cutaneous nerve transmission and provided analgesia below the 
point of injection.Then 2ml(80mg) was injected in to the ulnar nerve at the level 
of elbow which produced blockade of the ulnar nerve distribution. 
 In 1902, HARVEY CUSHING(1) coined the term “Regional 
Anaesthesia”. Harvey Cushing blocked the brachial plexus and sciatic plexus by 
direct vision under general anaesthesia inorder to reduce the intra operative 
anaesthetic requirements as well as to provide post operative analgesia. 
 In 1908, AUGUST BIER(1) (1861-1949) described Intravenous Regional 
anaesthesia. He injected procaine in to the vein  of upperlimb by applying two 
tourniquets. 
In 1911,G.HIRSCHEL(1) described the axillary block by blind injection 
technique. D.KULENKAMPFF(1) described the SUPRACLAVICULAR 
BRACHIAL PLEXUS BLOCK by elicitngParaesthesia  technique . In his study 
Kulenkampff placed the needle superficial to the first rib and the pleura. He 
injected the local anaesthetic solution in to his own plexus with 10ml of 
procaine at the mid-clavicular position lateral to subclavian artery. Because of 
the risk ofcomplications like pneumothorax and mediastinal emphysema, 
MULLEY (1)modified Kulenkampff„s technique and described the lateral 
paravertebral approach which is now known as the „Winnie block‟.  
                                               
  
In CARL SCHLEICH (1859-1922)(2) introduced the  technique of 
infiltrating local anaesthetic solution in a diluted form (0.01%-0.2%) as an 
alternative to direct injection of nerve trunks. 
LEONARD CORNING (1862-1934)(2) placed tourniquet that prevented 
blood loss. HENRICH F.BRAUN (1862-1934) (2) prolonged the effect of 
cocaine by adding Epinephrine which was described as „CHEMICAL 
TOURNIQUET‟. In 1905, Braun introduced Procaine which is less toxic than 
cocaine.Heinrich Braun wrote a book on local anaesthesia which was first 
translated in English and published in the year 1914. 
In 1911,G.HIRSCHEL(2) was the first person to introduce the technique 
of percutaneous brachial plexus block through axillary approach. Later it was 
modified by GEORGE PITKIN(2) and R.H.DE JONG(2) which remains 
popular even today. 
In 1917,BAZY(2) and V.PAUCHET(2) described infraclavicular 
approach of brachial plexus block which was later popularized by P.RAJ(2) in 
the year 1973. In 1912,M.KAPPIS (2)described the posterior paravertebral 
approach but there were high incidence of failure rate hence J.ETIENNE, 
V.PAUCHET and G.PITKIN(2) described anterior approach to the brachial 
plexus block.                                   
In 1970,ALON P.WINNIE(2) introduced the technique of interscalene 
approach of Brachial plexus block. Winnie emphasized  that scalene muscles 
  
are more accurate landmark to locate the brachial plexus block than mid-
clavicular position and subclavian artery. 
 In 1905, ALFRED EINHORN(2) synthesized procaine and used it till 
1932. Later in 1930‟s long acting drug the Tetracaine and Dibucaine  were 
synthesized. In 1943, LOFGREN(2) and LUNDQUVISIT (2)synthesized 
Lignocaine and it was  introduced by TORSTEN GORDH(2) in 1948. In 1952 
chloroprocaine was synthesized. In 1957 mepivacaine was synthesized. In 1963, 
EKENSTAM (2)synthesized Bupivacaine and TELIVUO(2) introduced 
bupivacaine in to clinical practice. In 1996 Ropivacaine was synthesized.  
 
 
 
 
 
 
 
 
 
 
 
 
  
ANATOMICAL CONSIDERATIONS 
The Brachial Plexus is situated superficially and can be easily  blocked 
for upper limb surgeries as well as for post operative analgesia.   
 
FORMATION OF BRACHIAL PLEXUS:(3)(2)(1)(4)(5) 
 The brachial plexus is formed by the union of  anterior primary rami of 
fifth,sixth,seventh,eighth cervical vertebrae and first thoracic vertebrae. 
Sometimes the fourth cervical vertebra contributes to the plexus which is 
referred as the pre-fixed type and a contribution from second thoracic vertebra 
to the plexus is referred as the post-fixed type. 
The roots emerges from the intervertebral foramina and passes behind the 
Foramen Transversarium and lies between the anterior and posterior tubercles 
of the transverse process. The roots lie inthe fibro-fatty space between the two 
sheaths in the groove formed between the scalenus anterior and scalenus 
medius. The anterior part of the sheath arises from  the anterior tubercles and 
covers the posterior aspect of scalenus anterior whereas the posterior part of the 
sheath arises from the posterior tubercles and covers the anterior aspect of 
scalenus medius. 
 
 
 
  
The sheath extends laterally along with the brachial plexus and enters the 
axilla.As they pass between the scalenus anterior and scalenus medius they are 
blocked by local anaesthetics .This technique is called the Interscalenae 
approach of brachial plexus block. 
These nerve roots emergesfrom the intervertebral foramina and converges 
to form trunks. These trunks are situated vertically but not always and are 
named accordingly as superior,middle and inferior trunk.The superior trunk is 
formed from the contributions of fifth and sixth cervical nerve roots, the middle 
trunk is contributed from the seventh cervical nerve root and the inferior trunk 
is formed from the contribution of eigth cervical and first thoracic nerve roots. 
The roots gives off few branches as well as receives few branches from 
the cervical sympathetic ganglion. They are,the roots of  fifth cervical (C5) and 
sixth cervical(C6) , each receives a grey ramus communicans from the middle 
cervical sympathetic ganglion. C7 and C8 each receives a gray ramus 
communicans from the inferior cervical sympathetic ganglion. The first thoracic  
root gives a white ramus to; and receives a grey ramus from the first thoracic 
sympathetic ganglion. From the roots of fifth, sixth, seventh, eigth cervical roots 
the nerves to longus colli and Scaleni is given off. The fifth cervical root gives 
nerve to rhomboids(dorsal scapular nerve). The fifth cervical roots gives a 
branch to phrenic nerve;which also receives contributions from third and fourth 
cervical roots. The fifth, sixth and seventh cervical root gives a branch to 
  
serratus anterior (long thoracic nerve of  Bell).  
The three trunks runs downwards and lateral to the lateral border of first 
rib just below the clavicle and divides in to anterior and posterior divisions. 
Once they divide they emerge below the clavicle and form thecords.The trunks 
gives off branches before they divide. They are, the nerve to subclavius from the 
front of  the   upper trunk (C5,C6); the supraclavicular nerve from the  outer part 
of  the upper trunk (C5,C6). The point of origin of the branches from the upper 
trunk is called Erb‟s point. 
The  three trunks as they run downwards and laterally across the posterior 
tuberclesof the vertebra  and then  across the first rib, they are blocked by 
supraclavicular ,subclavian perivascular approach and intersternocleidomastoid 
approach. The trunk gives off two branches before giving divisions.They are the 
suprascapular nerve C5,C6 and  Nerve to subclavius C5,C6 
The six divisions enters in to axilla and join as lateral,medial and 
posterior cord according to their relation with the axillary artery.Between the 
first rib and axilla the Brachial plexus are blocked by Infraclavicualrapproach. 
The lateral  cord is formed by the union of anterior division of superior 
trunk and middle trunk. The medial cord is formed by the contribution of  
anterior division of  inferior trunk. The posterior trunk is formed from the  
posterior divisionof all the three trunks. The cord once formed runs lateral to                           
the lateral border of  pectoralis minor muscle and gives off  major terminal 
  
branches.  
The lateral cord before continuing as musculocutaneous nerve C5,C6,C7, 
it gives off  the following two branches. They are  lateral division of median 
nerve C6,C7 and the lateral  pectoral nerve C5,C6,C7.  
 The medial cord before continuing as ulnar nerve it gives off the 
following four branches.They are medial division of median nerve C8,T1, 
medial cutaneous nerve of arm C8,T1,medial cutaneous nerve of forearm 
C8,T1,medial pectoral nerve C8,T1. 
 The posterior cord before terminates in to two major nerves  the  radial 
nerve C5,C6,C7,C8,T1 and axillary nerve C5 ,C6 it  gives off the following 
three  branches. They are the upper scapular nerve C5,C6,the  nerve to lattismus 
dorsi C6,C7,C8, and the lower subscapular nerve C5,C6.  
Relationship of Brachial plexus : 
  The roots lie between scalenus anterior and scalenus medius and lie 
above the second part of subclavian artery.The trunks are formed in the floor of 
the posterior triangle and are superficially placed.They are crossed by external 
jugular vein,trasverse cervical artery,inferior belly of omohyoid and 
supraclavicular nerve. 
The upper and middle trunks lie above the subclavian artery and the lower trunk 
lies behind the subclavian artery. The trunks bifurcates in to divisions at                                             
the lateral border of first rib behind the clavicle.  
  
 The cords are formed at the apex of axilla and around the axillary 
artery.Initially the medial cord lies behind the axillary artery, the posterior and 
lateral cord lies lateral to the axillary artery.But later behind the pectoralis minor 
the cords lie according to their names  as medial,lateral and posterior to axillary 
artery. 
SIGNIFICANCE OF FIRST RIB: 
The first rib lies in the horizontal plane slightly inclined downwards and 
forwards. It has head which articulates with the body of first thoracic vertebra. It 
has an  upper surface and two transverse grooves. The subclavian vein lies in 
the anterior groove. The subclavian artery and lower trunk of brachial plexus 
lies in the posterior groove.  Between the two grooves is the scalene tubercles 
where the scalenus medius is inserted. The outer border gives origin to serratus 
anterior. Importance of this first rib is it is kept as a guide to locate the plexus 
without puncturing the pleura.  
SUBCLAVAIAN ARTERY: 
It extends from its origin to the outer border of the first rib. The right 
subclavian artery is a branch from innominate artery which in turn is a branch 
from the arch of aorta and the left  subclavian artery is a branch from the arch of 
aorta. The brachial plexus lies parallel and lateral to the third part of  the 
subclavian artery. The third part of subclavian artery runs laterally and 
continues as the axillary artery. The terminal portion of the subclavian artery 
  
lies behind the clavicle at its mid-point. Here the inferior trunk of brachial 
plexus is situated posterior to the third  part of subclavian artery. The upper 
trunk is superior to the subclavian artery and the middle trunk is lateral to the 
subclavian artery. 
SUBCLAVIAN VEIN: 
 The subclavain vein is protected by the clavicle and it is very unlikely to 
be punctured. The anterior scalene muscle separates thesubclavian vein from the 
brachial plexus. 
TECHNIQUES OF BRACHIAL PLEXUS:(3) 
 1. Interscalene approach  
 
i.Anterior approach: 
 
a.Winnie 
 
b.Meier   
 
c.Modified lateral approach of Borgeat 
 
ii.Posterior approach: 
 
a.Kappis/pippa 
 
b.Boezaart 
  
2.Supraclavicular approach  
 
a. Classic supraclavicular approach of Kulenkampff  
 
b. Subclavian perivascular approach of Winnie and Collins. 
 
  
c.Modified lateral  paravascular approach of Moorthy 
 
     d.Plumb – bob technique 
 
3.Infraclavicular approach : 
 
a.Raj approach 
b.Coracoid approach 
c.Vertical infraclavicular approach 
4.Axillary approach : 
 
i.Transarterial injection 
ii.Paraesthesia Technique 
a.single injection technique  
b.Multiple injection technique 
1.INTERSCALENE BRACHIAL PLEXUS BLOCK: 
Anterior approach(Winnie in 1970) : (2)(4) 
 The roots of brachial plexusemerges out from the intervertebral foramina 
and  lies between the anterior  and middle scalene muscles.They lie superficial 
and posterior to the second and third part of the subsclavian atery. The dome of 
pleura lies anterolateral to the inferior trunk. 
          
Clinical Applications: 
Interscalene approach is suitable for surgeries involving the shoulder. The 
upper trunk and middle trunk is blocked. 
  
The Patient is explained about the procedure and made to lie insupine  
position with the neck extended and turned to the  contralateral side and the arm 
held in any  position.The interscalenae groove is palpated behind the 
sternocleidomastoid muscleby asking the patient to lift thehead slightly.The 
needle tip is inserted at the transverse process of sixth cervical vertebra which 
corresponds to  the  cricoid cartilage where the external jugular vein often 
crosses the sternocleidomastoid muscle.The 22 gauge, needle is inserted 
perpendicular to the skin and directed in amedial,dorsal and caudad at a 45º 
angulation.A click can be felt as the needle pierces the pre-vertebral fascia. The 
plexus is reached at a depth of  0.75cm-1.5cm. At a depth of 2cm the transverse 
process may be encountered, in such a situation the needle is walked across this 
structure to locate the plexus.Once  Paraesthesia is elicited in the upper arm or 
shoulder then the local anaesthetic solution of around 40ml is injected after 
confirming negative aspiration. The inferior trunk is often spared which is 
overcome to some extent by applying digital pressure superior to the injection 
site and downward massage along with 45 º head up position. 
                                                 
Complications: 
i. Phrenic nerve palsy(100% incidence) results in unilateral 
diaphragmatic paresis and  reduces pulmonary function by 25%. 
ii.injection in to vertebral artery results in convulsions. 
  
iii. injection in to Epidural  space 
  iv. injection in to Subarachnoid space 
v.Recurrent  laryngealnerve palsy results in hoarseness of voice 
vi.sympathetic chain involvement results in Horner‟s syndrome 
v.Pnemothorax is rare  
vi.Nerve damage or Peripheral neuritis. 
Drawback: 
The inferior trunk is not blocked hence not suitable for forearm and hand 
surgeries. 
MEIER APPROACH: 
      It is the modification of winnie approach in which the needle is directed 
at the posterior border of sternocleidomastoid cranially 2-3cm  at the level of 
superior thyroid cartilage. 
Modified lateral approach of Borgeat: 
   The needle is directed  along the interscalenae space at the level of cricoid 
cartilage towards the posterior part of  the upper and the middle trunk. 
   Interscalene(cervical approach): 
 The posterior approach was described by Kappis in 1912 and later by 
Pippa. In this technique the head is maximally flexed and the spinous process of 
C6 and C7 is palpated. Draw a line 3cm laterally  between the spinous processes 
of C6 and C7.Then insert the needle perpendicular to the skin and at 5-6cm 
  
distance  the transverse process of C7 vertebra  comes in contact with the 
needle.Then redirect the needle cranially where thebrachial plexus is situated 
and once contractions of the shoulder or abduction of arm occurs then the local 
anaesthetic is injected.                                                                       
Drawback: 
The lower trunk is spared so the intercostobrachial nerve has to be 
blocked in the medial aspect of arm for tourniquet tolerance. 
Boezaart approach: 
The needle is inserted at 45º angulation in a V shaped groove between the 
anterolateral border of trapezius muscle and the posteromedial border of levator 
scapulae  and 30º caudad towards the sternal notch. 
 Side-Effects: 
i.Phrenic nerve palsy 85%-100% 
ii.Horner‟s syndrome 75% 
iii.Recurrent laryngeal nerve palsy  20%                                                           
iv.Vessel puncture 
v.Pneumothorax(rare) 
Contraindications: 
Contralateral phrenic nerve palsy or recurrent laryngeal nerve palsy 
 
 
  
1. SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK 
Clinical Applications: 
Indicated for surgeries on the elbow, forearm and hand.The distal trunk and 
the proximal division is blocked.  
A.Classic Supraclavicular Block: 
Position: Supine with neck extended and turned to contralateral side . 
  At the mid clavicular line at 1cm posterior to the clavicle and lateral to 
thesubclavian  artery the needle is directed posteriorly caudally and medially. If 
the first rib is encountered the needle is systematically walked anteriorly and 
posterioly to locate the brachial plexus. 
Complications: 
Pneumothorax 0.5%-6% 
Phrenic nerve palsy 40% to 60% 
Horner‟s syndrome 
Peripheral neuropathy 
Cervical sympathetic nerve blockade.                                            
B) Subclavian Perivascular Technique of Winnie and Collins:  
This is the technique followed in this study. 
Clinical Applications: 
The Brachial plexus are arranged in a compact space as they cross the 
first rib. The blockade of three trunks are blocked reliably.  
  
Position:  
The patient lies in aSupineposture  with neck extended and turned to the 
contralateral side.The arm to be anaesthetized is held in adducted position. The 
posterior border of the sternocleidomastoid muscle is palpated easily when the 
patient raises the head slightly. The palpated fingers can then roll over the belly 
of the anteriorscalene muscle in to the interscalene groove,where a mark is 
made  1.5 to 2.0cm posterior to the midpoint of the clavicle. Palpation of the 
subclavian artery at this site confirms the landmark. The 22 gauge needle is 
inserted posterior,medial, caudad to the subclavian artery; by eliciting 
paraesthesia at the elbow  30ml of 0.375% of Inj. Bupivacaine with0.2mmols( 
0.1ml) of Inj.potassium chlorideis injected in Group BK or 30ml of 0.375% of  
Inj.Bupivacaine with0.17mmol(0.2ml) of  sodium bicarbonate is injected in 
Group BS.                                                
Complications:  
Pneumothorax 0.5% sometimes manifests after 12-24 hours   
Horner‟s syndrome 
Phrenic nerve palsy 
Hemothorax 
Hematoma formation 
Drawback: 
The area supplied by Ulnarnerve is spared. 
  
C) Modified lateral  paravascular approach of Moorthy: 
The needle is directed laterally ,posteriorly and caudally along the course of the 
subclavian artery towards the axilla medial and inferior to the subclavian artery. 
D.Plumb Bob Technique: 
The  plumb bob technique involves insertion of  the needle at the point 
where the lateral border of the sternocleidomastoid muscle inserts in to the 
clavicle.  After raising the skin wheal a 22 gaugeneedle is inserted which 
mimicks a plumb bob suspended over the needle entry site. Once paraesthesia 
is elicited 40ml of local anaesthetic solution is injected. 
3.INFRACLAVICULAR BRACHIAL PLEXUS BLOCK: 
 
i.  Raj approach 
ii.Coracoid approach                                                      
iii.Vertical infraclavicular approach 
Raj Technique: 
The needle is inserted 2.5cm below the midpoint of the clavicle. The axillary 
artery is aimed at the‟‟ brachial line‟‟ in the axilla. The brachial line runs from 
the transverse process of sixth cervical vertebra to the axillary artery in the 
axilla. 
Drawback: 
Technical difficulty 
Lower success rate 
  
Coracoid approach: 
The needle is inserted 2cm medial and 2cm caudal to the coracoid 
process,Posterior and perpendicular to the skin and at about 4cm distance the 
cords of brachial plexus is located. 
Vertical infraclavicular approach: 
Between the ventral apophysis of acromion and the jugular notch the needle is 
directed lateral to axillary artery and  axillaryvein at 4cm depth and thebrachial 
plexus is blocked. 
Advantages:  
Simple to perform 
High success rate                                                   
Tourniquet toleranceis good 
Patient position is comfortable  
Catheter insertion is simple 
Complications: 
Pneumothorax 
Hemothorax 
Chylothorax (left side is more common) 
4.AXILLARY BLOCK: 
i.Transarterial injection 
ii.Paraesthesia Technique 
  
a.single injection technique  
b.Multiple injection technique 
Axillary block  was first described by Halstead in 1884. 
Position: 
Supine with the arm in abduction of 90º.Palpate for the axillary artery 
pulsationat the mid- axillary fossaand go transarterially and inject the local 
anaesthetic. Also single needle or multiple needles are used. High success rate 
with multiple needle technique.                                   
Advantages: 
No possibility of  pneumothorax 
No  Stellate ganglion block 
No  Recurrent laryngeal nerve palsy 
No  Phrenic nerve palsy 
Complications: 
 Intra arterial injection 
Post operative neuropathy 
Hematoma 
Infection 
 
 
                                  
 
  
PHYSIOLOGICAL CONSIDERATION:(2)(4)(1) 
 
INTRODUCTION: 
 
 Most local anaesthetics block voltage-gated sodium channels from inside 
the cell. Not all the nerve fibres are equally sensitive to local anaesthetics .The 
sensitivity is determined by the degree of myelination,axonal diameter,and 
various other anatomic or physiologic factors. Local anaesthetics produce 
transient sensory, motor and autonomic loss.  
 
CLASSIFICATION OF  PERIPHERAL NERVES ACCORDING TO 
ANATOMY,PHYSIOLOGY, AND  FUNCTION: 
The A fiber has four subtypes; they are alpha, beta, gamma and delta. The 
A alpha fibres are heavilymyelinated . The diameter of the nerve fibre is 6-
22µm. They conduct at a velocity of 30-120msec, and carry the motor 
sensation. These fibres are sensitive to local anaesthetics.  
The A beta fibre are heavily myelinated. The diameter of the nerve fibre 
is 6-22µm and conducts at a velocity of 30-120msecs. They carry tactile and 
proprioception. They are susceptible to local anaesthetics. 
The A gamma fibre are myelinated . The diameter is 3-6µm and conducts 
at a velocity of 15-35 msecs.They carry  motor sensation. They are more 
susceptible to local anaesthetics. 
                               
  
The A delta fibres are myelinated . The diameter is 1-4µm and conducts 
at a speed of 5-25msecs. They carry pain,cold temperature and touch sensation.  
They are susceptible to local anaesthetics. 
The B fibres are myelinated . The diameter is less than 3µm and conducts 
at a velocity of 3-15msecs. They carry preganglionic autonomic sympathetic 
functions. They are susceptible to local anaesthetics. 
The C fibres are subdivided into sympathetic sC fibres and dorsal dC 
fibres. The sympathetic C fibre is not myelinated . It has a diameter of 0.3-
1.3µm and conducts at a velocity of 0.7-1.3. They carry various autonomic 
functions. The dorsal dC fibre is not myelinated. It has a diameter of 0.4-1.2µm 
and conducts at a velocity of 0.1-2.0msec. They carry various autonomic 
functions, pain ,warm temperature,touch. They are less susceptible to local 
anaesthetics. 
THEORIES OF LOCAL ANAESTHETIC ACTION: 
The cell membrane of neuron permits potassium ion more readily than 
sodium ion. Hence the intracellular anions accumulates and a negative charge is 
maintained(-70mV). 
The neurons maintains a voltage difference of the membrane potential of 
-60 to -90mV. The sodium and potassium pump transports three sodium ions for 
every two potassium ions. This creates a concentration gradient between  
           
  
intarcellular and extracellular ions thereby the diffusion of potassium ions 
extracellularly and diffusion of sodium ions intracellularly occurs. According to 
Nernst equation(2) the nerve at rest behaves like a‟‟ potassium electrode‟‟. 
According to the „‟CORE MANTLE EFFECT‟‟ the arrangement of 
nerves with in a plexus is not random, those supplying the distal structures in its 
territory lie at the centre or core whereas those supplyingthe more proximal 
areas are in the outer layer or mantle. In most mixed  peripheral nerves the 
proportion of motor and sensory fibres is same in both mantle and core but not 
the case with brachial plexus. Large proportion of core fibres are those 
providing rich sensory innervation to hand and mantle predominantly motor to 
shoulder and elbow. The first sign of successful brachial plexus is weakness of 
either shoulder or elbow joint.   
NEUROTRANSMITTERS: 
The inflammatory mediators involved in the transmission  of pain are 
substance P, Bradykinins, potassium, cytokines, histamine, serotonin, 
prostaglandins. These neurotransmitters  activate or sensitise the peripheral 
nociceptors to pain. 
ACTION POTENTIAL: 
The neurons have voltage-gated sodium and potassium channels that 
responds to a mechanical ,electrical,chemical stimuli when depolarisation  
occurs at -55mV.The sodium channel are activated leading to influx of sodium 
  
ions and generates action potential and conducts the impulse via nerve axon. If 
the depolarization exceeds a threshold level of -55mV, the voltage gated 
sodium channels are activated. So a sudden spontaneous influx of sodium ions 
occurs and hence an action potential is generated. The increase in sodium ions 
intracellularly causes a reversal of membrane potential of  +35mV . 
Subsequently a rapid decrease in sodium permeability  occurs along with an 
increase in potassium conductance through voltage gated potassium channels 
so that more potassium exits from the cell rendering the cell to return to a 
resting state. 
The Sodium channels has one alpha subunit and one or two beta subunits. 
The alpha subunit is larger and beta subunit is smaller.The voltage gated  
sodium channels exists in three states  namely  in resting, activated and 
inactivated state. 
         The local anaesthetics bind to alpha subunit and thereby they block the 
voltage gated channel of sodium from inside the cell and with increase in the 
concentration of local anesthetic the impulse conduction is slow and the action 
potential magnitude decreases and the impulse propogation is abolished.  
          The local anaesthetics have affinity to activated and inactivated state of 
sodium channel and hence they are voltage and time dependent. They also 
block the potassium,calcium and NMDA receptors.Drugs like 
Amitriptyline,Meperidine,Ketamine and Volatile anaesthetics blocks the 
  
sodium channels. Tetrodotoxin bind to sodium channel. 
The sensitivity to blockade depends on the diameter of axon,degree of 
myelination.Small diameter and lack of myelination sheath enhances the 
sensitivity.  
        Local anaesthetics consist of lipophilic group – a benzene ring and a 
hydrophilic group- a tertiary amine.and separated by an ester or amide 
linkage. 
 They are weak base and carries a positive charge to the tertiary amine group. 
Based on the intermediate chain, the local anaesthetics  are classified as 
amides or esters. 
The physicochemical properties of the local anaesthetics depends on the 
substitutions in the aromatic ring and intermediate chain linkage and alkyl 
group attached to amine nitrogen. 
The potency correlates with lipid solubility.If lipid soluble the drugs 
easily penetrates the cell membrane.The lipid solubility and thereby the 
potency increases with the increase in total munber of carbon atom in the 
molecule.The potency of local anaesthetic is affected by the myelination, size 
of fiber,pH,frequency of nerve stimuli and the electrolyte concentration like  
hypercalcemia,hypokalemia which antagonize the block. 
 The onset of local anaesthetic depends on lipid solubility and the 
concentration of non-ionized form and the ionized water soluble which 
  
depends on the pKa. The onset of action of local anaesthetic directly correlates 
with the pKa.The pKa of lignocaine is 7.8 and that of bupivacaine is 8.1. The 
pKa of a compound is defined as the pH at which its ionized form is equal to 
the un-ionized form.The local anaesthetics are prepared as water soluble 
hydrochloride salt pH(6-7).The pH of local anaesthetic solution  with 
adrenaline ranges from 4 to 5 as adrenaline is unstable at a pH of 6-7. The 
carbonated solution of local anaesthetic than hydrochloride salt has shortened 
onset of action.Differential sensory blockade may be desirable in selection of 
local anaesthetics and only Ropivacaine and  Bupivacaine has some selectivity 
for sensory nerve. 
Alkalinization of local anaesthetic liberates the free base, the 
carbondioxide rapidly diffuses in to the axon interior and the pH falls, which 
forces the dissociation of local anaesthetic to the active cation form. This effect 
results in „‟ion trapping‟‟. Further favouring the rapid movement of local 
anaesthetic in to the axon. 
  The three major factors that determine the conduction-blocking profile of the 
local anaesthetics are the following: 
1.Lipid solubility- Approximately 90% of cell membrane is composed of 
lipids. Local anesthetics are highly lipid soluble, and are able to penetrate the 
neuronal membrane  more readily than less lipid soluble agents.This is 
reflected biologically in their increased potency. 
  
2.Protein binding- Local anaesthetic agents which bind readily to proteins 
(eg.Sodium channels) hence prolong the activity 
3.pKa-The speed of onset of  local anaesthetic is directly related to the rate of 
penetration through  the neuronal membrane,which  in turn related to the 
amount of drug available in its non-protonated base form.when injected into 
tissue at physiologic pH(7.4),the percentage of drug present in base form is 
inversely related to its pKa. Local anaesthetics with  pKa value close to 
physiological pH will have more rapid onset than those with higher pKa 
values. 
 
 
 
 
 
 
 
 
 
 
 
 
  
PHARMACOLOGY 
MECHANISM OF LOCAL ANAESTHETICS:(2)(4)(6) 
Local anaethetics when deposited near the nerve;there occurs hydrolysis 
of aminoesters resulting in the penetration of the free drug in to the nerve 
sheath. The local anaesthetics permeate the axon membrane and resides in the 
axoplasm.The pH depends on the pKa of the individual drug. 
The local anaesthetics binds to the voltage –gated  sodium 
channelsthereby conformational change occurs and inhibits it. During the onset 
and recovery the partial and incompletely blocked nerve fibres are further 
inhibited that causes additional use dependent (phasic action)  binding to 
sodium channels. The rate of onset and recovery depends on sole diffusion of 
local anaesthetics.Prolonged blockade occurs by the dissociation from sodium 
channels in few seconds. 
PHARMACOKINETICS OF LOCAL ANAESTHETICS: 
Local anaesthetics are weak bases that has a pKa value above the 
physiological pH. Hence <50% of local anaesthetics exists as non-ionized 
state.Local anaesthetics with pKa  nearer to physiologic pH have more rapid 
onset of action.  
Absorption: 
The local anaesthetics have rapid onset but shorter duration of action 
when injected in to the sub-arachnoid space and sub-cutaneously. The onset of 
  
of intrathecal bupivacaine is 5 minutes whereas in brachial plexus block it is 20 
to 30 minutes. This occurs because the local anaesthetic is deposited at some 
distance from the nerve and it takes time to diffuse through various barriers. The 
systemic absorption  which depends on: 
i.Site of injection:Higher the vascularity more is the absorption. 
ii.Presence of vasoconstrictors:  The addition of adrenaline can  
decrease the absorption and increases the uptake , enhance the quality and 
prolongs the duration of action . The addition of adrenaline to lignocaine 
prolongs the duration but when adrenaline is added to bupivacaine it has little or 
no significanteffect. 
iii. Local anaesthetic agent: 
Highly tissue bound are more slowly absorbed. They have intrinsic vasodilator 
property except for the cocaine which is a vasoconstrictor. 
Distribution: 
It depends on tissue perfusion:Highly perfused organs has rapid uptake. 
Tissue/blood partition coefficient: 
Lipid solubility is responsible for the rapid uptake whereas protein binding is  
responsible for longer  duration of action. 
Tissue mass:Muscle is the greatest reservoir for local anaesthetics. 
 
 
  
Metabolism and Elimination: 
Esters: 
Esters are metabolised by Pseudocholinesterase.Procaine and benzocaine are 
metabolized to p-aminobenzoicacid  which are allergic. 
Amides: 
   Amides are metabolized inliver by microsomal P-450 (N-
dealkylationandhydroxylation) .In cirrhosis of liver,congestive cardiac failure, 
the dosage of bupivacaine and other amides should be reduced. 
Effects on organ system: 
A.Central nervous system: 
It is vulnerable for toxicity. Early symptoms include circumoral 
numbness,Paresthesia of tongue,dizziness,tinnitus and blurred vision, 
restlessness,agitation,paranoia,nervousness,slurred speech,drowsiness, 
seizures,unconsciousness. 
For seizures :Inj.Midazolam 0.3mg/kg ; Inj. Thiopentone 1-2mg/kg to be given. 
B. Respiratory system: 
Relaxation of  bronchial smooth muscles Apnea occurs  due to depression 
of medullary centre of respiration. 
C.Cardiovascular system: 
Depression of myocardial automaticity, contractility and conduction.The 
dose required to produce cardiovascular toxicity is three times than that of 
  
central nervous system. The effects are tachycardia,hypertension or hypotension 
atrio-ventricular block,arrhythmia,ventricular tachycardia and ventricular 
fibrillation. 
D.Immunological: 
 Due to the the preservative Methylparaben. They inhibit the inflammatory  
response  that activates the neutrophils by lysophosphatidic acid. 
E.Musculoskeletal system: 
`Local anaesthetics are myotoxic so necrosis can occur on intramuscular 
injection. 
F.Hematological: 
Lignocaine decreases coagulation and enhances fibrinolysis. 
Drug interaction: 
The local anaestheic action is potentiated by succinyl choline, 
opioids,alpha adrenergic agonist, cimetidine, propranolol, sodiumbicarbontae 
and potassium. Their effect is inhibited by Dibucaine. 
 
 
 
 
 
                      
  
BUPIVACAINE: 
 
Introduction: 
 
Bupivacaine  is an amide local anaesthetic. The drug was synthesized by 
EKENSTAM in 1957 but was clinically used in the year 1963 by TELIVUO. 
The structure of Bupivacaine is  same as mepivacaine with a butyl group in  
piperidine ring which is  responsible for high lipid solubility and protein 
binding. 
Structure of bupivacaine: 
Bupivacaine hydrochloride is chemically 2-piperidine carboxamide,1- 
butyl-N-2,6 dimethyl phenyl monochloride, monohydrate. Bupivacaine 
molecule is a tertiary amine, separated from aromatic ring system by an  
intermediate chain. This chain contains the amide linkage (-NHCO), hence it is 
classified as an aminoamide compound. This amide linkage     contributes to 
anaesthetic potency. The aromatic ring system gives  lipophilic character to its 
portion of molecule 
Mechanism of action: 
 
 Bupivacaine blocks the impulse by reducing the current through voltage 
activated sodium channels and  prevents opening of the channel by inhibitory 
conformational changes.Clinically the order of loss of nerve function is as 
follows: 
 
  
1.pain 
2.Temperature 
 
3.Touch 
 
4.Proprioception 
 
5.Skeletal muscle tone 
 
Metabolism: 
 
     Bupivacaine is metabolized by aromatic hydroxylation in liver . The 
piperidine side  chain is metabolised  to form pipecolylxylidine(desbutyl 
bupivacaine). It is one-eighth as  toxic as bupivacaine.Both desbutyl 
bupivacaine and unchanged  bupivacaine are slowly excreted in equal 
proportions in the urine, only 5%  bupivacaine is excreted unchanged in 
urine.Most important plasma protein binding site is alpha -1 - acid glycoprotein. 
Safety dose: 
 
Adrenaline does not have any effect on absorption 
 
Maximum single dose            -2-3mg/kg 
 
Concentration used: 
 
Peripheral nerve block                        - 0.25% -0.5% 
 
 
Spinal anaesthesia  - 0.5%  
 
Infiltration                                          - 0.125%-0.25% 
 
 Epidural          -0.125%-0.75%       
 
 
  
Characteristics of Bupivacaine: 
 
Side-Effects: 
 
1.ALLERGIC REACTIONS : 
 
Allergic reactions are very rare to Bupivacaine as it does not get 
metabolized to para amino benzoic acid like ester group of local anaesthetics. 
2.CROSS-SENSITIVITY: 
Cross sensitivity occurs due to  the  metabolite para amino benzoic acid of ester 
group of  local anaesthetics. So  a patient with  a known allergy to ester group of  
local anesthetic can receive amide group of local anaesthetic. 
pKa 8.1 
Volume of distribution 0.4-0.9 litres/kg 
Clearance 0.47 litres/kg 
Protein binding 95% 
Peak time of action 0.15-0.5hrs 
Half-life 1.2-2.4hrs 
Peak plasma concentration 0.8µg/ml 
Toxic plasma concentration >3µg/ml 
  
3.SYSTEMIC TOXICITY: 
Systemic toxicity of local anaesthetic  occurs when the  plasma 
concentration of the drug exceeds the prescribed level.  Toxicity depends upon 
the accidental direct injection of local anaesthetic in to the intravascular 
compartment or by systemic absorption. The magnitude of systemic absorption 
depends upon: 
i. Dose administered 
ii. Vascularity of the injection site 
iii. Presence of epinephrine in the solution 
iv. Physicochemical properties of the drug. 
The systemic absorption is greater in the intercostal nerve block, 
intermediate for epidural and least for brachial plexus block. 
4.CENTRAL NERVOUS SYSTEM: 
 Low plasma concentration produces numbness of tongue and circumoral 
tissues. As the plasma concentration is increased it crosses blood brain barrier 
and produces the following effects: Initial symptoms are restlessness, 
tinnitus,vertigo, difficulty in  focusing.Later slurred speech, skeletal muscle 
twitching over the face, extremities, drowsiness, tonic-clonic seizures, 
hypotension, apnea. The plasma concentration of Bupivacaine at  which 
seizures occurs is 4.5-5.5µg/ml. The cause of seizures is depression of   
inhibitory cortical neurons by local anaesthetics in the central nervous system. 
  
Another explanation is inhibition of  gamma amino butyric acid in the temporal 
lobe or amygdala  by local anaesthetics.  
Treatment: 
Oxygen, Benzodiazepines, Muscle relaxants and Intermittent positive 
pressure ventilation,Hyperventilation(as hypercapnia and aciodosis decreases 
the protein binding of the  local anaesthetic). 
5.CARDIOVASCULAR SYSTEM: 
A.Direct cardiac effects: 
Bupivacaine is more cardio toxic than central nervous system.It is more 
resistant to toxic effects of high plasma concentration of local anaesthetics than 
central nervous system. Bupivacaine dissociates more slowly than lignocaine 
and blocks the sodium channels  during diastole. Toxicity is enhanced by 
acidosis, hypoxemia, hypercarbia. Accidental intravascular injection causes 
hypotension, cardiac dysrhythmias, atrioventricular block, pregnancy increases 
the sensitivity of bupivacaine to cardiac toxicity due to increased free drug that 
occurs as a result of low alpha 1- acid glycoprotein. Tachycardia enhances 
frequency dependent blockade of sodium channels.The threshold for cardiac 
toxicity for bupivacaine may be decreased in patients on beta blockers, calcium  
channel blockers,and on digitalis. Epinephrine and phenylephrine 
increases the cardio toxixity of Bupivacaine by enhancing  the inhibition of  
cyclic Adenosine mono phosphate. The electrocardiograph changes would be 
  
prolonged P-R interval, QRS interval, re-entry ventricular dysrhythmias.The R- 
enantiomer of bupivacaine is more cardiotoxic than S – enantiomer. 
Treatment: 
Lipid emulsion:Bolus 1.5 ml/kg over 1min.Continuous infusion 0.25ml/kg. 
Repeat bolus once or twice persistent cardiovascular collapse double the 
infusion rate to 0.5ml/kg/min.Recommended upper limit is approximately 
10ml/kg.   
Inj.Bretylium 5 to 10mg/kg i.v or i.m every 10 to 30 mins to a maximum dose 
of 30mg/kg. 
B.Direct peripheral vascular effects: 
Local anaesthtetics exerts biphasic effect on the peripheral vascular 
smooth muscles. Low concentration of Bupivacaine produces vasoconstriction 
whereas at high concentration produces vasodilatation . Exception to this is the 
Cocaine which produces vasoconstriction at all concentrations. 
6.LOCAL TISSUE TOXICITY: 
 Bupivcaine when injected intramuscularly produces skeletal muscle 
damage which is more potent and more localized  than  lignocaine and  
prilocaine. But this effect is reversible and muscle regeneration occurs more 
rapidly with in two weeks. 
 
 
  
POTASSIUM CHLORIDE: 
Potassium ion is the second most common cation in the body. The 
concentration of potassium in the extracellular compartment is 4 meq/Litre and 
in the intracellular compartment it is 150meq/Litre .the total potassium present 
in the body is 3500mequivalents approximately. Potassium ion is a catalyst of 
numerous enzymatic reactions. It is also involved in the function of excitable 
cell membranes of nerves, skeletal muscle and cardiac muscles and  is directly 
involved in the function of kidney. 
A nerve impulse can  be effectively blocked by an accumulation of 
potassium ions  outside  the neuron.Thus blockade produced by bupivacaine is 
re-inforced and prolonged by  increased potassium ion  concentration out of the 
nerve membrane as a result of the  administration of exogenous potassium 
chloride.  
 Each 10ml ampoule contains 20mmoles of potassium ions, 1ml contains 
2mmoles. The concentration in which it is available is 15%.  In this study 
potassium chloride used is 15% of 0.2mmol of potassium chloride in 30ml of 
0.375% of bupivacaine.  
 
 
 
  
SODIUM BICARBONATE: 
Alkalinization (carbonation) of Bupivacaine increases the  pH>6 and thus 
it is less dependent on the buffering capacity of the tissues pH=7.4). On 
injection of this alkalinised solution the    free base is liberated, carbondioxide 
rapidly diffuses into the axon interior and here the pH falls, which forces 
dissociation of local anaesthetic to the active cationic form. This effect results in 
„ion-trapping‟ further favouring the rapid movement of the local anaesthetic into 
the axon. In this study it is used as 7.5% of 0.17mmol/litre ( 0.2ml) in 30ml of  
0.375% of bupivacaine. 
The sodium bicarbonate is available in 7.5% and 8.4% concentrations in 
10ml ampoule. In this study the 7.5% concentration is used. It consists of 
893mmoles of sodium bicarbonate in one litre in 7.5% concentration. In this 
study 0.2ml(0.17mmoles)  of 7.5% of sodium bicarbonate is  added to 30ml of 
0.375% of Bupivacaine solution. 
 
 
 
 
 
 
  
MATERIALS AND METHODS 
This is a prospective randomizedsingle blinded study conducted at 
Government Rajaji Hospital, attached to Madurai Medical College, Madurai. 
Sixty patients of ASA grade I&II of either sex undergoing upper limb surgeries 
were randomly allocated into two groups; the Group BK and Group BS. Each 
group comprises of 30 patients. The  brachial plexus block is performed with 
the patient lying supine with the head turned to contralateral side. Surgery was 
done under Subclavian perivascular approach of Brachial plexus Block by 
eliciting paraesthesia technique. The drug received by the two group are: 
GROUP BK: 0.375% of Inj.Bupivacaine  30ml + Inj.Potassiumchloride 
0.2mmol 
 (4 units in a Insulin syringe=0.1ml) 
GROUP BS: 0.375% of Inj.Bupivacaine 30ml +Inj.Sodiumbicarbonate 
0.17mmol 
(8 units in a insulin syringe =0.2ml)  
The following parameters were noted. 
1.The onset of sensory loss 
2.The onset of motor blockade 
  
3.The duration of surgery 
4.Intraoperative vital parameters(Pulse rate, Blood pressure, SPO₂, Respiratory 
rate, Electrocardiography) 
5.Tourniquet tolerance 
6.Duration of motor blockade 
7.Duration of sensory blockade 
8.Complications. 
INCLUSION CRITERIA: 
1.Age>18yrs 
2.Both sexes 
3.ASA I & II 
4.Weight>40kg 
EXCLUSION CRITERIA  
1.Patient‟s refusal  
2.Infection at the puncture site 
3.Patients with documented neuromuscular disorders  
4.Patients with hyperkalemia  
5.Patients with respiratory compromise                             
  
6.Patients with known allergy to local anaesthetic drug   
7ASA grade III and IV patients  
8.Psychiatric illness 
9.BMI> 35 
 10. Pregnancy 
 11.Bleeding diathesis 
 12. On Anti-coagulants 
 13.Peripheral Neuropathy 
PreOperative period: 
The following investigations were done: Hemoglobin, Random blood 
sugar, Serum Electrolytes, Urine- albumin and sugar, Chest x-ray, 
Electrocardiogram. 
Procedure: 
   After ethical committee approval, an informed consent was obtained from the 
patients.The patients are explained about the procedure in their own mother 
tongue regarding the paraesthesia that will be elicited during the technique 
which is perceived as a „‟electric shock‟‟ like or „‟tingling‟‟ sensation in the 
elbow or in the fore-arm. Once the patient experiences the sensation he or she  
has to communicate with the performer.Then  anintravenous access is secured 
and all the necessary monitors like SPO₂,Non- invasive blood pressure and  
                                                                    
  
Electrocardiogram were connected. Anaesthesia machine checked and all the 
resuscitative equipments like endotracheal tube,laryngoscope, and drugs like 
calcium gluconate, midazolam, thiopentone, atropine, adrenalinewere kept 
ready and proceeded with the block. 
All Patients were premedicated with a Inj.Midazolam 0.1mg/kg 
intramuscular to reduce anxiety one hour before surgery.  
Technique: 
The patient is positioned in supine, with the head turned 30º to the 
contralateral side and the  arms are held in  adduction position close to  his or 
her  body .A shoulder roll is kept in such a way to produce an head down of 
30º.The area of neck is aseptically painted and draped. The posterior border of 
the sternocleidomastoid  muscle is traced from the mastoid process to the 
insertion at the sternal and clavicular joint.The posterior edge of the 
sternocleidomastoid muscle is easily palpated by asking the patient to lift the 
head which makes it prominent. The subclavian artery is palpated from the 
lateral edge of the clavicular head of sternoclavicular joint at the level of sixth 
cervical vertebra. 
An intradermal wheal is raised approximately 1cm above the midclavicular 
point. A 22 gauge intramuscular needle  which  is connected to the  extension  
                                                     
  
  
tube with a 10ml syringe and a second anaesthetist is ready with loadedlocal 
anaesthetic solution to inject the drug . The needleis inserted posterior, 
downwards and in a medial direction and slowly walked in for eliciting 
paraesthesia. Once paraesthesia is elicited,30ml of 0.375% of inj. Bupivacaine 
with Inj. potassium chloride 0.2mmol in Group BK or 0.375% of inj. 
Bupivacaine with inj. sodium bicarbonate 0.17mmol in Group BS is injected by 
the second anaesthetist after confirming negative aspiration.  
The time of onset of sensoryblock , is recorded using pinprick in fourth 
cervical tofirst thoracic dermatome once in every one minute till the blockade 
occurs.There after every one hour till patient regained normal sensations.The 
onset of sensory block is the time of injection of drug to time of loss of pain on 
pinprick. The sensory blockade is assessed and scored as follows. 
SENSORY BLOCKADE  IS SCORED AS: 
0-No pain 
1-Mild grimace 
2-Moderate pain-Withdrawal 
3-Severe pain-Screams 
The time of onset of motor blockade is recorded by modified Bromage score. 
It is assessed every one minute till the motor blockade occurs. Thereafter every 
one hour it is assessed till recovery of motor power ( flexion of elbow) . 
                                
  
MODIFIED BROMAGE SCORE: 
0 :Able to raise extended arm to 90 º for 2secs 
1 : Able to flex elbow and move fingers but unable to raise the extended arm 
2 : Unable to flex the elbow but able to move the fingers 
3 : Unable to move arm, elbow, fingers. 
 The duration of surgery , the duration of sensory block, the duration of 
motor block, the vital parameters and complications were recorded. The 
duration of sensory blockade was the time of onset of sensory block to the 
recurrence of pain to pinprick. The duration of motor blockade was the time of 
onset of loss of movements to the recurrence of movements.  
The heart rate ,blood pressure , arterial saturation were recorded every 5 
minutes intraoperatively.  The patients were monitored for bradycardia, 
hypotension, convulsions,restlessness, disorientation, drowsiness or any other 
complications.   
 The quality of sensory and motor blockade was assessed based on the 
sensory and motor blockade as,  complete  sensory and motor blockade,  some 
sparing of sensory and motor blockade and required supplemental drugs to 
continue surgery or total failure of sensory or motor blockade  . 
                             
  
Grade 1: No supplemental drugs like opioids or sedatives  arerequired in the 
intra operative period to continue the surgery  
Grade 2:  Analgesics and sedatives are given as supplementation due to 
inadequate blockade.  
Grade 3: Due to complete failure  of  the  blockade and hence converted to 
general anaesthesia and  these patients are excluded from the study.   
The change in pH observed in this study: 
 
 
                          
 
 
 
0.5%20ml of Bupivacaine pH 5 
0.375% of 30ml Bupivacaine pH 5 
0.375%  of Bupivacaine with 0.1ml of potassium chloride pH 5 
0.375%  of Bupivacaine with 0.2ml of sodiumbicarbonate pH 7 
  
DATA ANALYSIS 
Statistical Tools ( To be included at the end of Materials and Methods) 
The information collected regarding all the selected cases were recorded 
in a Master Chart. Data analysis was done with the help of computer using 
Epidemiological Information Package (EPI 2010) developed by Centre for 
Disease Control, Atlanta. 
Using this software range, frequencies, percentages, means, standard 
deviations, chi square and 'p'  values were calculated. Kruskul Wallis chi-square  
test was used to test the significance of difference between quantitative 
variables and Yate‟s chi square test for qualitative variables. A 'p' value less 
than 0.05 is taken to denote significant relationship. 
 
 
 
 
 
 
 
 
 
 
 
                      
  
OBSERVATION AND RESULTS 
Group BK :Patients receiving 0.375% bupivacaine (20cc of 0.5% 
bupivacaine + 10cc of normal saline) with 0.2 mmol (4units in a insulin 
syringe=0.1ml)  of 15% of inj.potassiumchlorideGroup BS : Patients 
receiving 0.375% bupivacaine (20cc of 0.5% Bupivacaine + 10cc of normal 
saline) with0.2ml of 7.5% of  inj.Sodiumbicarbonate 0.17mmol(8units in a 
insulin syringe=0.2ml) 
Table 1 :  Age distribution 
 
Age group 
Age in years 
Group BK 
 
Group BS 
Range 18 – 60 yrs 18 – 60 yrs 
Mean 40.7 yrs 37.9 yrs 
SD 14.3 yrs 14.5 yrs 
„p‟ 0.4717  
Not significant 
Age distribution in Group BK varies from 18-60years with a mean value of  
40.7 and  Standard deviation of 14.3 years. In Group BS it varies from  18-
60years with a mean value of 37.9 years and standard deviation of 14.5 years 
On comparing both groups p value is 0.4717 which is not significant. 
                            
  
Table 2 : Sex distribution 
 
Sex 
Group BK Group BS 
No % No % 
Male 23 76.7 28 93.3 
Female 7 23.3 2 6.7 
Total 30 100 30 100 
„p‟ 0.5 
Not significant 
Sex distribution in Group BK Males were 23 and females were 7 whereas  
In Group BS males were 28 and females were 2 whose p value is 0.5 which is 
statistically not significant.  
 
 
 
  
Table 3 : ASA Grade 
 
ASA Grade 
Group BK Group BS 
No % No % 
I 24 80 22 73.3 
II 6 20 8 26.7 
Total 30 100 30 100 
„p‟ 0.7602 
Not significant 
In Group BK 24 patients come under ASA I and 6 in ASA II whereas in  
Group BS 22 patients come under ASA I and 8 in ASA II which are  
Statistically not significant 
                               
 
 
  
 
 
 
4.BMI 
 
 
 
 
 
 
 
 
 
 
 
The BMI in Group BK ranges between 21.2-24.0with a mean of 23.2 and 
standard deviation 1.8 and in Group BS the BMI ranges from  21.6-24.2 with a 
mean of 23.8 and standard deviation of 4.6 whose p value is not significant. 
 
 
   
 
Group 
BMI 
Range Mean S.D. 
Group BK 21.2–24.0 23.2 1.8 
Group BS 21.6– 24.2 23.8 4.6 
„p‟ 0. 2675 
Not Significant 
  
Table 5 :  Time of onset of sensory block 
 
Parameter 
Time of onset of sensory block 
(in minutes) 
Group BK Group BS 
Range 6-8 8 – 11 
Mean 7.63 9.83 
SD 0.56 0.64 
„p‟ 0. 0001 
Significant 
In Group BK the mean onset time for sensory block is 6-8mins, Standard 
deviation is 0.56 , whereas in Group BS the range is 8-11mins with a mean of 
9.83mins and Standard deviation  of 0.64 whose p value is 0.0001  which is 
statistically significant 
 
                            
  
Table 6 :  Time of motor onset  
 
Parameter 
Time of motor onset  
(in minutes) 
Group BK Group BS 
Range 3 – 4 5 – 6 
Mean 3.9 5.2 
SD 0.31 0.41 
„p‟ 0. 0001 
Significant 
In Group BK the onset of motor block ranges from3-4mins with a mean of 3.9mins 
And Standard deviation of 0.31whereas in Group BS the range varies from 5-6mins 
with a mean of 5.2,With a Standard deviation of 0.41 whose p value is significant. 
                            
  
  
Table  7:  Duration of Surgery 
 
Parameter 
Duration of Surgery  
( in minutes) 
Group BK Group BS 
Range 60 – 90 60-90 
Mean 88 83 
SD 14.1 18.1 
„p‟ 0. 0147 
Significant 
In Group BK the duration of surgery varies from 60-90mins with a mean of 
88mins and   standard deviation of 14.1 and in Group BS it ranges from 60-
90mins with a mean of  83 and standard deviation of 18.1 whose p value is 
0.0147 which is not significant. 
 
                               
  
 
 
Table 8: Torniquet Tolerance 
Tourniquet tolerance is Good in 28 patients and fair in 2 in Group BK  Whereas it is 
Good  in 29 patients and fair in 1 patient in Group BS whose p value is0.5   Which is  
not statistically significant.The fair category of patient did not require  supplemental 
analgesics or sedatives. 
 
Torniquet Tolerance 
 
Group BK 
 
Group BS 
No. % No. % 
Good 28 93.3 29 90 
Fair 2 6.7 1  10 
„p‟ 0.5 
Not significant 
  
                              
Table 9: Quality of Anaesthesia 
 
Quality of 
anaesthesia 
 
Group BK 
 
Group BS 
No. % No. % 
Grade 1 28 93.3 29 90 
Grade 2 2      6.7 1 10 
„p‟ 0.5 
Not significant 
      The quality of anaesthesia is graded as grade 1 in 28 patients and grade 2 in 2  
patients in Group BK  Whereas it is grade 1 in  29 patients and grade 2 in 1 patient in 
Group BS whose p value is 0.5 which is  not statistically significant.The grade 1 did 
not require any supplemental drugs like opioids or sedatives; the grade 2 patients 
received opioids and sedatives to proceed with surgery. 
  
                               
 
Table  9: Systolic Blood Pressure  
 
Group 
Systolic Blood Pressure (mm/Hg) 
Range Mean S.D. 
Group BK 100 - 140 117 13.2 
Group BS 100 – 140 119 13.7 
„p‟ 0. 555 
Not Significant 
In Group BK the systolic blood pressure  varies from 100-140mmHg with a 
mean of 117mmHg and   standard deviation of 13.2 and in Group BS it ranges 
from 100-140mmHg with a mean of  119 and standard deviation of 13.17 , 
whose  p value is 0.555 which is not significant 
        
  
 
Table 10 :Diastolic Blood Pressure 
 
 
 
 
 
 
 
 
 
In Group BK the Diastolic blood pressure varies from 60-90mmHg with a mean 
of 70.7mmHg and standard deviation of 8.3 and in Group BS it ranges from 60-
90mmHg with a mean of  70.3 and standard deviation of 8.1,whose p value 
is0.9425  which is not significant 
 
 
 
 
Group 
Diastolic Blood Pressure(mm/Hg) 
Range Mean S.D. 
Group BK 60 – 90 70.7 8.3 
Group BS 60 – 90 70.3 8.1 
„p‟ 0. 9425 
Not Significant 
  
Table 11:Pulse Rate 
 
 
 
 
 
 
 
 
 
 
In Group BK the pulse Rate varies from 60-92/min with a mean of  
75.9/min and   standard deviation of 75.9 and in Group BS it ranges f60-94/min 
with a mean of  76 and standard deviation of 9.3 which is not significant. 
                                
 
Group 
Pulse Rate 
Range Mean S.D. 
Group BK 66 – 92 75.9 7.3 
Group BS 60 – 94 76 9.3 
„p‟ 0. 8236 
Not Significant 
  
 
Table  12 :SPO₂ 
 
Group 
SPO₂ 
Range Mean S.D. 
Group BK 97 – 99 98.5 0.7 
Group BS 97 – 99 98.5 0.7 
„p‟ 1.0 
Not Significant 
 
In Group BK the Spo₂ varies from 97%-99% with a mean of 98.5% and   
standard deviation of 0.7 and in Group BS it ranges from  97%-99% with a 
mean of  98.5% and standard deviation of 0.7 whose p value is 1.0  which is not 
significant 
 
  
  
 
Table  13:  ECG changes 
 
 
Group 
Complications 
Present Absent 
No % No % 
Group BK - - 30 100 
Group BS - - 30 100 
 
In Group BK and in Group BS there were no ECG changes 
 
 
 
  
  
 
 Table 14 :Sensory Block Duration 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In Group BK the duration of sensory blockade the varies 420-480mins  with a 
mean of 476.6mins and Standard deviation of 13.2. In Group BS 600-720 mins 
with a mean 608 mins and Standard deviation of 26.1 and the P value between 
the two groups is significant. 
                              
 
Group 
Sensory Block Duration 
( in minutes) 
Range Mean S.D. 
Group BK 420 – 480 476.6 13.2 
Group BS 600 – 720 608 26.1 
„p‟ 0. 0001 
Significant 
  
 
Table 15 :Duration of Motor Block  
 
Group 
Duration of Motor Block 
( in minutes) 
Range Mean S.D. 
Group BK 240 – 270 245 11.4 
Group BS 360 – 420 417 12.1 
„p‟ 0. 0001 
Significant 
In Group BK the duration of motor block ranges from 240-270mins with a 
mean of 245mins and Standard deviation  of 11.4 and in Group BS the doration 
ranges from    360-420mins with a mean of 417mins and Standard deviation 
12.1 whose p value is 0.0001 which is statistically  significant 
 
                              
  
 
Table 16 :  Complications 
 
Group 
Complications 
Present Absent 
No % No % 
Group BK - - 30 100 
Group BS - - 30 100 
 
In Group BK and Group BS complications like nausea ,vomiting. Hypotension,  
hypertensionTachycardia. Bradycardia. 
      
 
  
REVIEW OF LITERATURE 
1.British Journal of Anaesthesia [1986 Mar, 58(3):297-300] 
A double blinded comparison of prilocaine and prilocaine with potassium 
chloride and of  plain bupivacaine with bupivacaine plus potassium chloride, in 
brachial plexus blockade by axillary approach was obtained in two groups of 20 
patients. They observed that addition of potassium chloride 0.2mmol to a 
solution of 0.25% Bupivacaine  40ml for brachial plexus blockade has 
advantages over the use of the plain solution. The sensory blockade suitable was 
achieved by 25mins (it takes a minimum of 30mins for axillary block with a 
plain solution to be suitable for surgery). The addition of potassium chloride 
0.2mmol resulted in a more rapid onset of sensory loss. 
2.British Journal of Anesthesia 1966;38:857-864 
 Bromage,P.R et al., and Burfoot,M.F et al.(1966): He conducted a 
comparative study between lignocaine with potassium chloride and lignocaine 
with hyaluronidase in epidural anaesthesia which revealed that hyaluronidase 
impairs the quality of sensory blockade rather than enhancingit,whereas 
potassium chloride gave rise to a shortened latency of spread and a more intense 
quality of sensory blockade.  
 
  
          3.M.D.Bedder et al and associates :Anesthesia  Analgesia 1988;67:68: 
  A comparative study between Bupivacaine and alkalinized bupivacaine in 
brachial plexus block was conducted between two groups of 30 patients in each 
group. Group I received 0.5%bupivacaine (pH,5.5) 3mg/kg, while Group II 
received alkalinized bupivacaine 0.5% (pH,7.05-7.15) 3 mg/kg. The onset of 
sensory block, motor block was assessed. The time to onset of sensory 
blockade(Group I,17.7±1.8min and in Group II ,16.3±0.9min) did not differ 
significantly between the groups. Similarly, no difference in time to onset of 
motor blockade (Group I,6.9±1.7min and in Group II 6.3±1.5min) or time to 
peak motor effect(GroupI 18.1±1.9min; Group II, 15.1±1.9mins ) was observed. 
Regression of post operative sensory and motor blockade was similar in both 
groups. 
4.Indian Journal of Anaesthsia 2003;47(4):283-286. 
Dr.Ruby Mehtal ,Dr.D.D.Verma,Dr.Veena Gupta ,Dr.A.K.Gurwara et al 
conducted a study and observed that alkalinization of 2% lignocaine 
hydrochloride with adrenaline leads to alteration in its onset of action and 
duration of action. 60 patients between the age group 20-60years were subjected 
to the study.Group I received 20ml of lignocaine  hydrochloride with adrenaline  
                        
  
 
(pH=3.21). Group II received 20ml of freshly prepared solution by addition of 
1mlof 7.5% sodium bicarbonate to standard solution (pH=6.21). Group III 
received 20ml of alkalinized standard solution prepared by addition of 2ml of 
7.5% sodiumbicarbonate (pH=6.67).Supraclavicular brachial plexus block was 
performed . The onset of sensory  block,onset of motor block,quality of block 
and duration of block was assessed.It was observed that raising the pH of 
solution from 3.21 to 6.21 produced a reduction in latency of sensory block. 
(18.35 minutes to 10.35minutes),a reduction in latency of motor block (20.65 
minutes to 12.2minutes) and increased in the duration of block.Further increase 
of pH from 6.21 to 6.67 did not confer any added advantage. Frequency of 
complete block in solution with pH6.21 was seen to increase as compared to pH 
3.21 solution(35% to 80%). 
5.Masui Journal of Anaesthesia 2006; 62 : 116-118 
  A comparative study between two groups of patients (200 each), one 
group receiving hyaluronidase mixed anaesthetic and the other 
sodiumbicarbonate buffered anaesthetic. Peribulbar block was performed.The 
groups were compared  
                               
 
  
 
for effectiveness of the anaesthesia, its onset, duration of blockade. They 
concluded that sodium bicarbonate was shown to reduce the time of onset of 
sensory block and to increase the quality of blockade without anyadverse 
effects. 
6.  Indian journal of Anaesthesia 1990;38:119-122. 
  Khosa DS, Thind SS,  Gupta HK, Jain et al  conducted a study  where  
potassium chloride was added to lignocaine and bupivacaine solutions in 
brachial plexus block.  The time of onset of sensory block , motor block and 
duration of analgesia was noted. They concluded that addition of potassium 
chloride to bupivacaine in brachial plexus block significantly enhanced the 
onset of sensory blockade and prolonged the total duration of analgesia when 
compared to lignocaine. 
7. British journal of Anaesthesia 1983; 
 Kircha SS, Barsa J,Fink BR et al. conducted a study and observed that 
Potentiation of nerve block in vivo by physiological adjuvants in the solution. 
Addition of potassium chloride doubled the duration of blockade produced by a 
solution of lignocaine in plain isotonic sodium chloride whereas conduction in 
isolated nerve can be accelerated by raising the extraneural potassium  
  
concentration. 
8.Hardy et al performed a study to assess the minimum concentration of 
bupivacaine on stellate ganglion block, and the effect of potassium chloride 
added to  bupivacaine. He concluded that potassium chloride has a major effect 
on the minimum concentration of bupivacaine for sympathetic blockade. 
9.Parris and Chamber et al conducted a study and concluded that potassium 
chloride made no differences to the characteristics of the block with 
prilocaine,but resulted in a more rapid onset of sensory loss when added to 
bupivacaine. 
10.Fink and Calkins et al conducted a study and concluded that conduction in 
isolated nerve can be accelerated by raising the extraneural potassium  chloride 
concentrations. 
11. Ritchie et al confirmed that the cation is the anaesthetically active form of 
local anaesthetic and uncharged molecule is essential for penetration  in to the 
intracellular receptor site. The alkaline solution are more effective in sheathed 
preparations. Bupivacaine 0.5% has a pKa of 8.1. When sodiumbicarbonate 
added to Bupivacaineit  results in rapid onset of sensory block and increased  
the quality of blockade. 
                                                    
  
12.Galindo et al concluded that pH adjusted  solutions of local anaesthetics 
pH(7-7.4). produced a more rapid onset of blockade and duration of 
analgesia.pH adjusted bupivacaine was studied using a prospective randomized 
double blinded design in epidural analgesia for parturients.0.25% Bupivcaine 
with the pH increased from 5.65 to 7.26 was used. The time of onset of sensory 
blockade was reduced while the time to reach peak effect was unaffected with 
alkalinization. A statistically  significant increased duration of analgesia was 
observed (79.4 Vs 96.5 mins) with alkalinized bupivacaine 0.25% 
13. Hilgier et al compared 0.5% bupivacaine with epinephrine 1:200,000 (pH 
3.9) with an alkalinized solution of bupivacaine with 1:200,000 (pH 6.4) when 
used for brachial plexus block. He reported that alkalinization of the 
bupivacaine solution increases onset and prolongs the duration of sensory 
blockade in subclavian perivascular brachial plexus blockade. 
 
 
 
 
 
                             
 
  
DISCUSSION 
        Brachial plexus block is widely used in our day to day practice for elective 
as well as emergency upperlimb surgeries. It provides better intra-operative as 
well as post operative analgesia. Inorder to provide  better quality of anaesthesia 
intraoperatively as well as to prolong the  duration of post operative analgesia 
various adjuvants are added to local anaesthetic solution. Among the adjuvants 
sodiumbicarbonate and potassium chloride have stood the test of time, apart  
from the opioids. 
             The addition of sodiumbicarbonate to Bupivacaine alkalinizes the pH of 
the local anaesthetic solution thereby  free base is liberated, ion trapping occurs 
and hence the onset of sensory block is enhanced rapidly. The addition of 
potassium chloride to Bupivacaine increases the extracellular concentration and 
depolarizes the nerve membrane and thus blocks the conduction of nerve 
impulses. The addition of potassium chloride to bupivacaine shortens the onset 
of sensory and motor blockade whereas the addition of sodiumbicarbonate to 
bupivacaine prolongs the duration of sensory and motor blockade in brachial 
plexus block. 
The addition of potassium chloride as an adjuvant to Bupivacaine  
solution will cause depolarization of the cell membrane and thereby it  
                             
  
provides better quality of analgesia, better tourniquet tolerance as well as 
prolongs the duration of analgesia . It also enhances the onset of sensory 
blockade which would be prolonged with plain bupivacine alone without any 
detrimental side effect even when injected intravascularly because 0.2mmoles 
of potassium chloride used in this study is too low to cause the cardiovascular 
complications.  
Sodium bicarbonate when added as an adjuvant to Bupivacaine will 
change the pH to alkaline state and thereby it enhances the onset of sensory 
blockade as well as provides better quality of analgesia, better tourniquet 
tolerance  and prolongs the duration of analgesia.   
       The addition of  potassium chloride and alkalinization of the local 
anaesthetic solution is used which is cost effective as well as do not have any 
adverse effect on the hemodynamic status of the individual.The  addition of 
carbonates and alkalinization have stood the test of time. 
             This study was carried out in sixty patients of ASA I and II with 
demographic data in terms of age, weight, sex, body mass index were similar in 
both the groups.   
The mean time of onset of sensory blockade in Group BK7.63mins, whereas in 
Group BS the mean time of onset of sensory block is 9.8mins. The   
                             
  
mean time of onset of motor blockade in Group BK  is  3.9mins ,whereas in 
Group BS the mean time of onset of motor blockade is 5.2 mins. The result of 
this study supports the findings of Khosa et al who showed that addition of 
potassium chloride to bupivacaine significantly enhanced the onset of both 
sensory and motor blockade.In contrast to this study the delayed onset of 
blockade proposed by Parris and Chamber et al may be due to the lower 
concentration  of  Bupivacaine (0.25%) when compared to this study (0.375%). 
 The quality of sensory and motor block was same in both the groups . 
The patients did not require supplemental analgesics or sedatives in both the 
group. Bromage and Burfoot also found the intense quality of blockade when 
potassium was added to lignocaine in epidural blockade. This is also correlates 
with the results of Parris and Chamber et al . 
 The duration of sensory and motor blockade was significantly increased 
in both the groups more so in BS group.This observation correlates with Khosa 
et al who found prolonged duration of analgesia. 
 
 
 
  
  
SUMMARY 
Sixty patients of ASA grade I&II of either sex undergoing upper limb surgeries 
were randomly allocated into two Groups BK and BS. Each group comprised of 
30 patients.  
GROUP BK: 0.375% of Inj.Bupivacaine + Inj.Potassiumchloride 0.2mmol 
(4 units in a Insulin syringe=0.1ml) 
GROUP BS: 0.375% of Inj.Bupivacaine +Inj.Sodiumbicarbonate 0.17mmol 
(8 units in a insulin syringe =0.2ml)  
Surgery was done under Subclavian perivascular approach of Brachial 
plexus Block. Supraclavicular brachial plexus block is given with the patient 
lying supine with the head turned to opposite side after eliciting paraesthesia.  
The onset and duration of sensory loss and motor blockade are studied.  
The loss of pinprick sensation is checked  in C4 toT2 skin dermatome every 1 
minute till the onset of loss of sensation and every 1 hourly till the regain of 
sensation. The motor blockade is assessed every 1 minute by modified Bromage 
score and every 1 hourly till the regain of movements. The following 
parameters were observed: 
 
 
  
1.Onset of sensory block 
2.Onset of motor block 
3.Duration of sensory block 
4.Duration of motor block 
5.Tourniquet tolerance 
6.Quality of block. 
7.Hemodynamic stability 
8.Complications 
Potassium chloride when added as an adjuvant to Bupivacaine has 
sensory onset of  6-8mins(7.63±0.56) and motor onset of 3-
4mins(3.9±0.31).Sodiumbicarbonate when added as an adjuvant to Bupivacaine  
has sensory onset of 8-11 mins(9.8±0.64) and motor onset of 5-
6mins(5.2±0.41).The duration of motor block is 240-270mins(245±11.4) in 
Group BK and 360-420 mins(417±12.1) in Group BS.The duration of sensory 
block is 420-480mins(476.6±13.2)in Potassium chloride BK group whereas the 
duration of sensory block is 600-720 mins(608±26.1) in Sodiumbicarbonate BS 
group. 
 
  
CONCLUSION 
Potassium chloride when added as an adjuvant to Bupivacaine has sensory onset 
(Range( mean±standard deviation)) of 6-8mins(7.63±0.56) and motor onset of 
3-4 mins(3.9±0.31) 
 Sodiumbicarbonate when added as an adjuvant to Bupivacaine  has sensory 
onset of 8-11 mins(9.8±0.64) and motor onset of 5-6mins(5.2±0.41) 
The duration of motor block is 240-270mins(245±11.4) in Group BK and 360-
420 mins(417±12.1) in Group BS. 
The duration of sensory blockade is 420-480mins(476.6±13.2) in Potassium 
Chloride group whereas 600-720 mins(608±26.1) in Sodiumbicarbonate group. 
Hence it is concluded that , in brachial plexus blockade, 
The addition of potassium chloride as an adjuvant to bupivacaine shortens 
the onset time of sensory and motor blockade whereas the addition of 
sodiumbicarbonate prolongs the duration of sensory and motor 
blockade.The quality of anaesthesia is good in both the groups. 
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STUDY PROFORMA 
1.NAME   :     
I.P.NO:                ASA: 
2.AGE& SEX  :    
 
3.WEIGHT  : 
 
4.DATE& TIME  OF ADMISSION : 
 
5.DIAGNOSIS : 
 
6.PROCEDURE : 
 
7.HISTORY :  ALLERGY TO DRUGS, BLEEDING   
  DISORDERS, SYSTEMIC ILLNESS 
 
8.CLINICAL EXAMINATION : PR,BP, SPO2,  ,BMI, 
CVS,RS,CNS 
9.BASIC INVESTIGATIONS : 
HAEMOGLOBIN- 
RENAL PARAMETERS- 
  
BLOOD SUGAR 
SERUM  ELECTROLYTES- 
CHEST X RAY PA VIEW- 
ECG- 
10.ANAESTHETIC TECHNIQUE: SUPRACLAVICULAR BRACHIAL 
PLEXUS BLOCK BY SUBCLAVIAN PERIVASCULAR APPROACH 
11.DOSAGE OF DRUG   : 
GROUPBK :INJ. BUPIVACAINE 0.375% (30ml)+ INJ. POTASSIUM 
CHLORIDE    0.1ML(0.2mmol/l) 
GROUP BS :INJ. BUPIVACAINE 0.375% (30ml)+ INJ. 
SODABICARBONATE 7.5%(0.2ml) 
12.SENSORY BLOCKADE    :  (Loss of Pin Prick at C4 to T2 Dermatome  
every 2 mins till blockade.) 
ONSET TIME:  
13.MOTOR BLOCKADE          : (Modified Bromage score): Every 2 
minstill Blockade 
14.TOURNIQUET TOLERANCE:Good or Fair 
15.QUALITY OF ANAESTHESIA:Grade 1/Grade 2/Grade 3 
SENSORY BLOCKADE  IS SCORED AS: 
0-No pain 
1-Mild grimace 
2-Moderate pain-Withdrawal 
3-Severe pain-Screams 
MODIFIED BROMAGE SCORE: 
0 : Able to raise extended arm to 90º for 2secs 
  
1 : Able to flex elbow and move fingers but unable to raisr the extended arm 
2 : Unable to flex the elbow but able to move the fingers 
3 : Unable to move arm, elbow, fingers. 
THE QUALITY OF ANAESTHESIA: 
Grade 1:No supplemental drugs like opioids or sedatives  are required in the 
intra operative period to continue the surgery  
Grade 2:  Analgesics and sedatives are given as supplementation due to 
inadequate blockade.  
Grade 3:Due to complete failure  of  the  blockade and hence converted to 
general anaesthesia and  these patients are excluded from the study.   
DURATION OF SURGERY : 
TOURNIQUET : TIME OF APPLICATION :               
 TIME OF DEFLATION : 
 
 
 
 
 
 
 
  
 
MONITORING OF VITALS EVERY 15 MINS : (ANXIOLYTICS, 
SEDATIVES, ANTI EMETICS AND OTHERS TO BE MENTIONED) 
 
VITALS 
5M
INS 
15MI
NS 
30MI
NS 
45MI
NS 
1H
R 
1.15H
RS 
1.30 
HRS 
2HR
S 
2.30
HRS 
PULSE          
B.P          
RR 
PATTER
N 
         
SPO2          
ECG          
SIDE 
EFFECTS 
         
REMARK
S 
         
 
 
 
 
 
 
 
 
 
  
 
 
 
POST OP PERIOD : MONITORING OF VITALS : 
 
 
RECOVERY OF SENSORY BLOCKADE : 
(TIME FROM BRACHIAL PLEXUS BLOCK UNTIL THE TIME AT 
WHICH PT REQUIRED POST OP ANALGESIA) 
(POST OP ANALGESIA GIVEN WHEN VAS(VISUAL ANALOGUE 
SCORE) SCORE GOES ABOVE 4) 
RECOVERY OF MOTOR BLOCKADE : 
(TIME AT WHICH PT COULD FLEX THE ELBOW). 
  
PARAMETERS 30MINS 1HR 2HR 4HRS 6HRS 8HRS 10HRS 12HRS 24HRS 
PULSE          
B.P          
RR          
SPO2          
VAS SCORE          
SIDE 
EFFECTS 
         
REMARKS          
  
                 GUIDE TO MASTER CHART 
ABBREVIATIONS USED IN MASTER CHART: 
F-Finger 
F1-Thumb 
F2-Ring finger 
F3-Middle finger 
F4-Ring finger 
F5-Little finger 
Rt-Right  
Lt-Left 
Amp-Amputation 
#-Fracture 
BB- Both Bone 
FA- Fore- Arm 
Dis Rad- Distal Radius 
Inj- Injury 
Tend- Tendon 
  
Dislcn- Dislocation 
cmc-Carpo meta carpal joint 
jt- joint 
SOR- Shaft of Radius 
Seg- Segment 
Gang- Ganglion 
Ze-Zone 
Gr-Grade 
SSG- Split skin graft 
ORIF- Open Reduction and internal fixation 
k-wire- Kirschner‟s wire 
Ex-Fix- External fixation 
Trmtic- Traumatic 
BE- Below Elbow 
Fix- Fixator 
Rev Amp- Revision Amputation 
  
 
  
 
  
 
  
  
 
  
 
 
 
 
  
 
 
 
  
PHOTOS & CHARTS 
THE BRACHIAL PLEXUS AND ITS RELATION 
WITH SUBCLAVIAN VESSELS 
 
 
  
THE BRACHIAL PLEXUS AND ITS RELATION WITH FIRST RIB 
 
 
THE SITE OF  SUPRACLAVICULAR BLOCK 
  
 
 
 
 
THE BRACHIAL PLEXUS AND ITS BRANCHES 
  
  
THE FORMATION OF  BRACHIAL PLEXUS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STRUCTURE OF BUPIVACAINE 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WALKING THE NEEDLE TO ELICIT PARAESTHESIA 
 
  
 
 
 
 
SUBCLAVIAN PERIVASCULAR APPROACH OF  
BRACHIAL PLEXUS BLOCK 
 
 
ALL THE THREE ROOTS OF BRACHIAL PLEXUS ARE 
ENCLOSED IN A SINGLE SHEATH 
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MOTOR  BLOCK ONSET TIME
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DURATION OF SENSORY BLOCK
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